Advanced tube-bundle rocket thrust chamber

An advanced rocket thrust chamber for future space application is described along with an improved method of fabrication. Potential benefits of the concept are improved cyclic life, reusability, and performance. Performance improvements are anticipated because of the enhanced heat transfer into the coolant which will enable higher chamber pressure in expander cycle engines. Cyclic life, reusability and reliability improvements are anticipated because of the enhanced structural compliance inherent in the construction. The method of construction involves the forming of the combustion chamber with a tube-bundle of high conductivity copper or copper alloy tubes, and the bonding of these tubes by an electroforming operation. Further, the method of fabrication reduces chamber complexity by incorporating manifolds, jackets, and structural stiffeners while having the potential for thrust chamber cost and weight reduction

Detection of beet soil-borne virus and beet virus Q in sugarbeet in Greece

Sugar beet plants with typical rhizomania symptoms were collected from the five major cultivation zones of Greece. The presence of Beet necrotic yellow vein virus (BNYVV), the primary causal agent of the disease, was ascertained by DAS-ELISA in 38 out of 40 fields surveyed and the positive samples were subsequently examined for the presence of other soil-borne viruses which are frequently associated with rhizomania, using a multiplex RT-PCR assay targeting BNYVV, Beet soilborne virus (BSBV) and Beet virus Q (BVQ). The occurrence of BSBV and BVQ was confirmed in 9 and 23 rhizomania-infected fields, respectively. In contrast to surveys conducted in other countries, the presence of BVQ prevailed throughout Greece in dual infections with BNYVV, whereas BSBV was restricted to rhizomania-infected fields from only two sugarbeet cultivation areas. Nine of the samples tested were infected with all three viruses. BSBV was always found in triple infections. To our knowledge, this is the first report of BSBV and BVQ in Greece. The future assessment of the impact of each of these viruses on sugarbeet could prove significant for bleeding objectives in terms of achieving a more durable resistance to the rhizomania syndrome

Hot fire fatigue testing results for the compliant combustion chamber

A hydrogen-oxygen subscale rocket combustion chamber was designed incorporating an advanced design concept to reduce strain and increase life. The design permits unrestrained thermal expansion of a circumferential direction and, thereby, provides structural compliance during the thermal cycling of hot-fire testing. The chamber was built and test fired at a chamber pressure of 4137 kN/sq m (600 psia) and a hydrogen-oxygen mixture ratio of 6.0. Compared with a conventional milled-channel configuration, the new structurally compliant chamber had a 134 or 287 percent increase in fatigue life, depending on the life predicted for the conventional configuration

New method of making advanced tube-bundle rocket thrust chambers

An improved method of fabrication rocket chambers for future space applications is described. Included are fabrication demonstrator and test chambers produced by this method. This concept offers the promise of improved cyclic life, reusability, and performance. The performance is improved because of the enhanced enthalpy extraction. The improved cyclic life, reusability, and reliability is improved because of the structural compliance inherent in the construction. The method of construction involves the forming of the combustion chamber by a tube-bundle of high conductivity copper or copper alloy tubes and the bonding of these tubes by a unique electroforming operation. Furthermore, the method of fabrication reduces chamber complexity by incorporating manifolds, and structural stiffeners while having the potential for thrust chamber cost and weight reduction

Hot fire test results of subscale tubular combustion chambers

Advanced, subscale, tubular combustion chambers were built and test fired with hydrogen-oxygen propellants to assess the increase in fatigue life that can be obtained with this type of construction. Two chambers were tested: one ran for 637 cycles without failing, compared to a predicted life of 200 cycles for a comparable smooth-wall milled-channel liner configuration. The other chamber failed at 256 cycles, compared to a predicted life of 118 cycles for a comparable smooth-wall milled-channel liner configuration. Posttest metallographic analysis determined that the strain-relieving design (structural compliance) of the tubular configuration was the cause of this increase in life

Experimental performance of a high-area-ratio rocket nozzle at high combustion chamber pressure

An experimental investigation was conducted to determine the thrust coefficient of a high-area-ratio rocket nozzle at combustion chamber pressures of 12.4 to 16.5 MPa (1800 to 2400 psia). A nozzle with a modified Rao contour and an expansion area ratio of 1025:1 was tested with hydrogen and oxygen at altitude conditions. The same nozzle, truncated to an area ratio of 440:1, was also tested. Values of thrust coefficient are presented along with characteristic exhaust velocity efficiencies, nozzle wall temperatures, and overall thruster specific impulse

Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli

OBJECTIVE Adherent-invasive Escherichia coli (AIEC) are a leading candidate bacterial trigger for Crohn's disease (CD). The AIEC pathovar is defined by in vitro cell-line assays examining specific bacteria/cell interactions. No molecular marker exists for their identification. Our aim was to identify a molecular property common to the AIEC phenotype. DESIGN 41 B2 phylogroup E. coli strains were isolated from 36 Australian subjects: 19 patients with IBD and 17 without. Adherence/invasion assays were conducted using the I-407 epithelial cell line and survival/replication assays using the THP-1 macrophage cell line. Cytokine secretion tumour necrosis factor ((TNF)-α, interleukin (IL) 6, IL-8 and IL-10) was measured using ELISA. The genomes were assembled and annotated, and cluster analysis performed using CD-HIT. The resulting matrices were analysed to identify genes unique/more frequent in AIEC strains compared with non-AIEC strains. Base composition differences and clustered regularly interspaced palindromic repeat (CRISPR) analyses were conducted. RESULTS Of all B2 phylogroup strains assessed, 79% could survive and replicate in macrophages. Among them, 11/41 strains (5 CD, 2 UCs, 5 non-IBD) also adhere to and invade epithelial cells, a phenotype assigning them to the AIEC pathovar. The AIEC strains were phylogenetically heterogeneous. We did not identify a gene (or nucleic acid base composition differences) common to all, or the majority of, AIEC. Cytokine secretion and CRISPRs were not associated with the AIEC phenotype. CONCLUSIONS Comparative genomic analysis of AIEC and non-AIEC strains did not identify a molecular property exclusive to the AIEC phenotype. We recommend a broader approach to the identification of the bacteria-host interactions that are important in the pathogenesis of Crohn's disease.This research was supported by an Australian Academy of Science France-Australia Science Innovation Collaboration early career fellowship; a Gastroenterological Society of Australia (GESA) Clinical Research grant; and funding from the Ministère de la Recherche et de la Technologie, Inserm (UMR1071), INRA (USC-2018); and Nouveau Chercheur EPST from Conseil Régional Auvergne

The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease

The differentiation of resident intestinal macrophages from blood monocytes depends upon signals from the macrophage colony-stimulating factor receptor (CSF1R). Analysis of genome-wide association studies (GWAS) indicates that dysregulation of macrophage differentiation and response to microorganisms contributes to susceptibility to chronic inflammatory bowel disease (IBD). Here, we analyzed transcriptomic variation in monocyte-derived macrophages (MDM) from affected and unaffected sib pairs/trios from 22 IBD families and 6 healthy controls. Transcriptional network analysis of the data revealed no overall or inter-sib distinction between affected and unaffected individuals in basal gene expression or the temporal response to lipopolysaccharide (LPS). However, the basal or LPS-inducible expression of individual genes varied independently by as much as 100-fold between subjects. Extreme independent variation in the expression of pairs of HLA-associated transcripts (HLA-B/C, HLA-A/F and HLA-DRB1/DRB5) in macrophages was associated with HLA genotype. Correlation analysis indicated the downstream impacts of variation in the immediate early response to LPS. For example, variation in early expression of IL1B was significantly associated with local SNV genotype and with subsequent peak expression of target genes including IL23A, CXCL1, CXCL3, CXCL8 and NLRP3. Similarly, variation in early IFNB1 expression was correlated with subsequent expression of IFN target genes. Our results support the view that gene-specific dysregulation in macrophage adaptation to the intestinal milieu is associated with genetic susceptibility to IBD.</p

Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome

Objectives: To assess associations between gingival crevicular fluid (GCF) markers in patients with metabolic syndrome, with or without concomitant periodontitis. Methods: A total of 95 patients with Metabolic Syndrome (MetS) had a periodontal examination and gingival crevicular fluid samples taken. Proteomic analysis of gingival crevicular fluid (GCF) was carried out by Human XL Cytokine protein arrays in 12 selected patients, followed by multiplex ELISA of 11 analytes in 95 participants. Results: Increased levels of Aggrecan, IL-6 and IL-8 were found in patients with periodontal health compared with moderate and severe periodontitis. The inverse stepwise association between severity of periodontitis and reduced Aggrecan levels was also observed at adjusted linear regression analysis. Diagnosis of diabetes was associated with higher GCF levels of IL-8 and MMP-8. Conclusion: Diabetes may affect GCF levels of cytokines, irrespective of periodontal status. Periodontal status may be associated with Aggrecan levels in the GCF of patients affected by metabolic syndrome. Clinical significance: Investigation of GCF biomarkers may potentially help have diagnostic potential in patients with MetS

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study.

INTRODUCTION: Crohn's disease and ulcerative colitis are common chronic idiopathic inflammatory bowel diseases (IBD), which cause considerable morbidity. Although the precise mechanisms of disease remain unclear, evidence implicates a strong multidirectional interplay between diet, environmental factors, genetic determinants/immune perturbations and the gut microbiota. IBD can be brought into remission using a number of medications, which act by suppressing the immune response. However, none of the available medications address any of the underlying potential mechanisms. As we understand more about how the microbiota drives inflammation, much interest has focused on identifying microbial signals/triggers in the search for effective therapeutic targets. We describe the establishment of the Australian IBD Microbiota (AIM) Study, Australia's first longitudinal IBD bioresource, which will identify and correlate longitudinal microbial and metagenomics signals to disease activity as evaluated by validated clinical instruments, patient-reported surveys, as well as biomarkers. The AIM Study will also gather extensive demographic, clinical, lifestyle and dietary data known to influence microbial composition in order to generate a more complete understanding of the interplay between patients with IBD and their microbiota. METHODS: The AIM Study is an Australian multicentre longitudinal prospective cohort study, which will enrol 1000 participants; 500 patients with IBD and 500 healthy controls over a 5-year period. Assessment occurs at 3 monthly intervals over a 24-month period. At each assessment oral and faecal samples are self-collected along with patient-reported outcome measures, with clinical data also collected at baseline, 12 and 24 months. Intestinal tissue will be sampled whenever a colonoscopy is performed. Dietary intake, general health and psychological state will be assessed using validated self-report questionnaires. Samples will undergo metagenomic, transcriptomic, proteomic, metabolomic and culturomic analyses. Omics data will be integrated with clinical data to identify predictive biomarkers of response to therapy, disease behaviour and environmental factors in patients with IBD. ETHICS AND DISSEMINATION: Ethical approval for this study has been obtained from the South Eastern Sydney Local Health District Research Ethics Committee (HREC 2019/ETH11443). Findings will be reported at national and international gastroenterology meetings and published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: ACTRN12619000911190